64 Ergebnisse wurden angenommen, darunter drei „Proffered Papers" und drei „Rapid-Oral"-Präsentationen, die mehr als zehn Bereiche der Onkologie und unterstützenden Behandlung abdecken. Mehr als zehn Studien befassen sich mit HER2- und HER3-spezifischen Antikörper-Wirkstoff-Konjugaten...
-Hengrui Pharma presenta en el Congreso ESMO 2026 64 resultados de investigación en su innovadora cartera de oncología Se han aceptado 64 hallazgos, incluidas tres presentaciones de trabajos y tres presentaciones orales rápidas, que abarcan más de diez áreas de la oncología y los cuidados...
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) will hold its official listing ceremony to mark the Company's name and ticker change, and first Investor Day at the Nasdaq Tower on Monday, Oct. 26. Subject to completion of the transaction, FFR management will provide 2026 full year guidance,...
RAEFORD, N.C., Oct. 20, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Kenneth Spells is acknowledged as a 2026 Professional of the Year for his contributions in Educational Leadership. Kenneth Spells has built a distinguished career in education leadership marked by...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hyliion Holdings Corp. (NYSE:HYLN) securities. If you suffered a loss on your Hyliion investment and would like to explore a potential recovery under the federal securities laws, Learn about Hyliion Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Hyliion Holdings Corp. that ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ:UNCY) securities. If you suffered a loss on your Unicycive Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Unicycive Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Honeywell Aerospace Inc. (NASDAQ:HONA) securities. If you suffered a loss on your Honeywell Aerospace Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Honeywell Aerospace Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired York Space Systems Inc (NYSE:YSS) securities. If you suffered a loss on your York Space Systems Inc investment and would like to explore a potential recovery under the federal securities laws, Learn about York Space Systems Inc Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf ..
64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. More than 10 studies have been selected to highlight the latest findings on HER2- and HER3-targeted...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Gildan Activewear Inc. (NYSE:GIL) securities. If you suffered a loss on your Gildan Activewear Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Gildan Activewear Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 20, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fluence Energy, Inc. (NASDAQ:FLNC) securities. If you suffered a loss on your Fluence Energy, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fluence Energy, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) Investors who purchased The Chemours Company securities between February 20, 2026 and August 4, 2026 have until December 7, 2026 to seek appointment as lead plaintiff NEW YORK CITY, NY / ACCESS Newswire / October 20, 2026 / Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE:CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Chemours and have suffered losses, you may CLICK ..